IDAC Theranostics Competitors and Similar CompaniesClear all

Takeda's competitors and similar companies include CureVac.
Takeda
Takeda
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Founding Date
Founding Date
1781
Founding Date
2000
Type
Type
Public
Type
Public
Tags
Locations
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Employees
Employees
47,4554% decrease
Employees
82517% decrease
Valuation ($)
Valuation ($)
43.7 b
Valuation ($)
648.3 m

Financial

Revenue (est.)
Revenue (est.)
¥4.6t (FY, 2025)
Revenue (est.)
€535.2m (FY, 2024)
Cost of goods
Cost of goods
¥818.8b (FY, 2025)
Cost of goods
€9.7m (FY, 2024)
Gross profit
Gross profit
¥3.8t (FY, 2025)
Gross profit
€534.4m (FY, 2024)
Net income
Net income
¥108.1b (FY, 2025)
Net income
€162.2m (FY, 2024)

Operating

Phase I Trials Products
Phase I Trials Products
2 (May, 2025)
Phase I Trials Products
3 (May, 2020)

Funding

Total funding raised
Total funding raised
$ 57.8m
Total funding raised
$ 1.1b
For sources of this data, please see the company profile

View Company Profiles

CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.

View company